Juries have awarded tens of millions of dollars to ovarian cancer victims, twice in the past three months, who has blamed Johnson & Johnson talcum powder for their illness. A St Louis jury on Monday ordered Johnson & Johnson to pay $55 million to a South Dakota survivor of the disease. In February this year, another St Louis jury has awarded $72 million to relatives of an Alabama woman who died of ovarian cancer.
Some case studies have indicated that women who regularly use talc on their genital area face up to a 40 per cent higher risk of developing ovarian cancer.
Attorney Jim Onder said Johnson & Johnson's marketing targeted overweight women, blacks and Hispanics, "knowing that those groups were most at-risk for talc-related ovarian cancer," he said. "It's horrible."
"Unfortunately, the jury's decision goes against 30 years of studies by medical experts around the world that continue to support the safety of cosmetic talc," Johnson & Johnson spokeswoman Carol Goodrich said in a statement.
"I will never use talc again. It's definitely concerning to me," Teri Brickey, forewoman of the jury, 45, told The Associated Press. "I think it's a potential health hazard for some women - a small percentage, but it is a percentage."
(And get your daily news straight to your inbox)
20% people are sleep deprived, finds survey. Every fifth person across the world is s
Patients with the rare form of diabetes called maturity-onset diabetes of the young (
A new study finds that bursts of neural activity takes place as the brain holds infor
Scientists at Nanyang Technological University has developed a smart chip that allows